Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, how much funding his Department plans to allocate for the (a) development and (b) validation of non-animal human-relevant scientific methods in each financial year until 2028-29.
UK Research and Innovation (UKRI) invests to support research which can lead to alternatives, such as organ-on-a-chip, cell-based assays, functional genomics and computer modelling. These are categorised as basic research, so calculating funding for alternative methods specifically is not possible. Future investment will be determined by internal allocations of DSIT’s spending review settlement announced on 11.06.25. UKRI also invests £10 million annually in the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and is conducting a five-year review to guide future investment.
The Government will publish a strategy to support non-animal alternatives later this year.